New Delhi, 15 Oct 2024: India’s apex drug pricing regulator Monday allowed a 50 percent rise in the prices of 8 essential drugs used by people with asthma, glaucoma, thalassemia, tuberculosis, and mental health disorders.

 

The decision comes following ......
View Details

Related News

• Supreme Court rejects plea alleging side effects of COVID-19 vaccines (15-10-2024)

---

• Consumer affairs minister slams air purifier firms for false claims (15-10-2024)

---

• Union Health Secretary addresses Annual India Leadership Summit (15-10-2024)

---

• Open sale of painkillers sparks addiction concerns (15-10-2024)

---

• 3 Directors of Gujarat pharma company, arrested in cocaine bust: Delhi Police (14-10-2024)

---

• 95% regulatory processes currently have been digitized at CDSCO: JP Nadda (14-10-2024)

---

• 11 countries recognised IP as their standard: DCGI Rajeev Raghuvanshi (14-10-2024)

---

• Glenmark arm recalls products in US for manufacturing issues (14-10-2024)

---

• DTAB asks DCC to look into inclusion of all antibiotics in the definition of new drugs to curb AMR (14-10-2024)

---

• DGFT extends RoDTEP scheme for pharma exporters until Dec 31 (14-10-2024)

---